ClearPoint Neuro (CLPT) Shareholder's Equity Growth (1y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.73% |
| Dec 31, 2025 | 10.36% |
| Sep 30, 2025 | -45.26% |
| Jun 30, 2025 | -38.56% |
| Mar 31, 2025 | -42.21% |
| Dec 31, 2024 | 19.91% |
| Sep 30, 2024 | 20.37% |
| Jun 30, 2024 | 17.23% |
| Mar 31, 2024 | 6.15% |
| Dec 31, 2023 | -42.60% |
| Sep 30, 2023 | -39.58% |
| Jun 30, 2023 | -35.99% |
| Mar 31, 2023 | -28.76% |
| Dec 31, 2022 | -24.39% |
| Sep 30, 2022 | -9.61% |
| Jun 30, 2022 | -10.73% |
| Mar 31, 2022 | 3.97% |
| Dec 31, 2021 | 1,952.46% |
| Sep 30, 2021 | 29,510.74% |
| Jun 30, 2021 | 3,482.23% |
| Mar 31, 2021 | 1,494.13% |
| Dec 31, 2020 | -48.17% |
| Sep 30, 2020 | -97.52% |
| Jun 30, 2020 | -80.61% |
| Mar 31, 2020 | 523.34% |
| Dec 31, 2019 | 203.71% |
| Sep 30, 2019 | 141.03% |
| Jun 30, 2019 | 94.06% |
| Mar 31, 2019 | -90.68% |
| Dec 31, 2018 | -74.09% |
| Dec 31, 2017 | 870.93% |
| Dec 31, 2016 | 61.84% |
| Sep 30, 2016 | 109.87% |
| Jun 30, 2016 | 32.59% |
| Mar 31, 2016 | 0.45% |
| Dec 31, 2015 | -1,874.62% |
| Sep 30, 2015 | 26.55% |
| Jun 30, 2015 | -30.44% |
| Mar 31, 2015 | -15.69% |
| Dec 31, 2014 | 98.53% |
| Sep 30, 2014 | -41.25% |
| Jun 30, 2014 | -59.95% |
| Mar 31, 2014 | -67.70% |
| Dec 31, 2013 | 13.11% |
| Sep 30, 2013 | 40.44% |
| Jun 30, 2013 | 73.74% |
| Mar 31, 2013 | 85.27% |
| Dec 31, 2012 | 63.99% |